Related Experiment Video
Updated: Jul 16, 2026

A Macrophage-Tumor Spheroid Co-Invasion Assay
Published on: January 24, 2025
Macrophage migration inhibitory factor induces MMP-9 expression in macrophages via the MEK-ERK MAP kinase pathway
Xiyong Yu1, Shu-Guang Lin, Xiao R Huang
1The Guangdong Provincial Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangzhou 510080, China.
Abstract:
We have shown previously that macrophage migration inhibitory factor (MIF) may play a role in the destabilization of atherosclerotic plaques by activating matrix metalloproteinase protein-9 (MMP-9). The aim of this study is to investigate the signaling mechanism by which MIF induces MMP-9 expression and activation in a murine macrophage line (RAW264.7). MIF was able to activate extracellular signal-regulated kinase 1/2 (ERK1/2), to a less extent JNK, but not p38 mitogen-activated protein (MAP), MAP kinase to induce MMP9 mRNA and protein expression in RAW264.7 murine macrophages. This was confirmed by the findings that addition of an ERK MAP kinase inhibitor (PD98059) but not a p38 inhibitor (SB203589) abolished MIF-induced MMP-9 expression and activation, whereas addition of a JNK inhibitor (SP600125) produced a partially inhibitory effect. The functional role of mitogen-activated protein kinase kinase (MEK)-ERK MAP kinase in MIF-induced MMP-9 expression was further confirmed by overexpressing dominant negative MEK (DN-MEK) and DN-ERK MAP kinases. Interestingly, constitutive expression of a wild-type (WT)-MEK alone was also capable of inducing a low, but significant MMP-9 mRNA and protein expression but did not cause a further increase in MMP-9 in response to MIF. MIF activates the MEK-ERK MAP kinase pathway to induce MMP-9 expression by murine macrophages. Activation of this pathway is necessary for MMP-9 expression and activation in response to MIF stimulation.
Insights
Macrophage migration inhibitory factor (MIF) activates the MEK-ERK pathway in macrophages, leading to increased matrix metalloproteinase-9 (MMP-9) expression and activation, contributing to atherosclerotic plaque destabilization.
Area of Science:
- Immunology
- Cardiovascular Biology
- Molecular Signaling
Background:
- Macrophage migration inhibitory factor (MIF) is implicated in atherosclerotic plaque destabilization.
- MIF's role may involve the activation of matrix metalloproteinase-9 (MMP-9).
Purpose of the Study:
- To elucidate the signaling mechanism by which MIF induces MMP-9 expression and activation.
- To investigate the specific mitogen-activated protein kinase (MAPK) pathways involved in MIF-induced MMP-9 regulation in murine macrophages.
Main Methods:
- Utilized RAW264.7 murine macrophage cell line.
- Assessed activation of ERK1/2, JNK, and p38 MAPKs by MIF.
- Employed specific MAPK inhibitors (PD98059, SB203589, SP600125) and dominant-negative constructs (DN-MEK, DN-ERK).
Main Results:
- MIF activated ERK1/2 and, to a lesser extent, JNK, but not p38 MAPK.
- Inhibition of ERK (PD98059) or JNK (SP600125) pathways significantly reduced MIF-induced MMP-9 expression and activation.
- Overexpression of dominant-negative MEK or ERK abolished MIF-induced MMP-9.
- Constitutive MEK expression induced basal MMP-9 but did not enhance MIF's effect.
Conclusions:
- MIF activates the MEK-ERK MAPK pathway to induce MMP-9 expression and activation in murine macrophages.
- The MEK-ERK pathway is essential for MIF-mediated MMP-9 regulation.
- This signaling axis is a key mechanism linking MIF to processes involved in atherosclerotic plaque instability.
